Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Lycera Expands Partnership With Merck for Potential $600 Million Deal
Feb. 14, 2013
Lycera doubled its sweet 2011 deal with Merck in a new agreement designed to expand on the companies’ prior relationship, which has centered on retinoic acid-related orphan receptor.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing